 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

PureTech Health plc (NASDAQ:PRTC  Get Free Report) shares saw strong trading volume on Monday . 1,918 shares traded hands during trading, a decline of 17% from the previous sessions...

PureTech Health (NASDAQ:PRTC) Sees Large Volume Increase

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a clinical-stage biotherapeutics company, noted today that its Founded Entity, Karuna Therapeutics...

PureTech Founded Entity Karuna Therapeutics Announces U.S. Food and Drug Administration Accepts New Drug Application for KarXT for the Treatment of Schizophrenia

PureTech Health plc (NASDAQ:PRTC  Get Free Report) was down 8.1% on Tuesday . The stock traded as low as $20.80 and last traded at $21.78. Approximately 3,835 shares changed hands during...

PureTech Health (NASDAQ:PRTC)  Shares Down 8.1%

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a clinical-stage biotherapeutics company, noted that its Founded Entity, Karuna Therapeutics (NASDAQ...

PureTech Founded Entity Karuna Therapeutics Announces Positive Results from Phase 1b Ambulatory Blood Pressure Monitoring Trial of KarXT in Schizophrenia

PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ('PureTech' or the 'Company'), a clinical-stage biotherapeutics company dedicated to changing the lives of patients with devastating...

PureTech's LYT-300 (Oral Allopregnanolone) Achieved Primary Endpoint in a Phase 2a Acute Anxiety Trial in Healthy Volunteers

Shares of PureTech Health plc (NASDAQ:PRTC  Get Free Report) gapped up before the market opened on Friday . The stock had previously closed at $18.00, but opened at $19.56. PureTech Health...

PureTech Health (NASDAQ:PRTC) Shares Gap Up to $18.00

PureTech Health plc (NASDAQ:PRTC  Get Free Report) shares saw an uptick in trading volume on Tuesday . 4,160 shares changed hands during trading, an increase of 145% from the previous...

PureTech Health (NASDAQ:PRTC) Sees Unusually-High Trading Volume

PureTech to Present at Two Upcoming Investor Conferences

PureTech Presents Data from LYT-100 (Deupirfenidone) Trial in Healthy Older Adults at CHEST Annual Meeting

PureTech Health plc (NASDAQ:PRTC  Get Free Report)s share price hit a new 52-week low during trading on Wednesday . The stock traded as low as $20.35 and last traded at $20.35, with a...

PureTech Health (NASDAQ:PRTC) Reaches New 52-Week Low at $20.35

PureTech Health Plc engages in the provision of differentiated medicines for devastating diseases, including inflammatory, fibrotic and immunological conditions, intractable cancers, lymphatic and gastrointestinal diseases and neurological and neuropsychological disorders. It operates through the following segments: Internal, Controlled Founded Entities, Non-Controlled Founded Entities, and Parent Company and Others. The Internal segment focuses on immunological, fibrotic, and lymphatic system mechanisms. The Controlled Founded Entities segment is composed of the group’s subsidiaries that are currently consolidated operational subsidiaries that either have or have plans to hire independent management teams and currently have already raised, or are currently in the process of raising, third-party dilutive capital. The Non-Controlled Founded Entities segment includes companies wherein the group no longer holds majority voting control as a shareholder and no longer has the right to elect a majority of the members of the subsidiaries’ Board of Directors. The Parent Company and Other segment represents activities that are not directly attributable to the operating segments, such as the activities of the parent, corporate support functions and certain research and development support functions that are not directly attributable to a strategic business segment as well as the elimination of intercompany transactions. The company was founded by Robert S. Langer Jr., Bennett M. Shapiro, and Daphne Zohar on May 8, 2015 and is headquartered in Boston, MA.

Watchers	73
52-Wk Low	$17.85
52-Wk High	$38.51

Market Cap	$414.61M
Volume (M)	2,470.00
52-Wk High	$38.51
52-Wk Low	$17.85

PRTC Puretech Health

About

Feed

News

Earnings

Fundamentals